INM
Price
$2.87
Change
-$0.29 (-9.18%)
Updated
Jun 6 closing price
Capitalization
3.86M
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
884.73K
61 days until earnings call
Interact to see
Advertisement

INM vs SQZB

Header iconINM vs SQZB Comparison
Open Charts INM vs SQZBBanner chart's image
InMed Pharmaceuticals
Price$2.87
Change-$0.29 (-9.18%)
Volume$208.32K
Capitalization3.86M
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$59.56K
Capitalization884.73K
INM vs SQZB Comparison Chart
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. SQZB commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a StrongBuy and SQZB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (INM: $2.63 vs. SQZB: $0.03)
Brand notoriety: INM and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 25% vs. SQZB: 3%
Market capitalization -- INM: $3.86M vs. SQZB: $884.73K
INM [@Biotechnology] is valued at $3.86M. SQZB’s [@Biotechnology] market capitalization is $884.73K. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, SQZB is a better buy in the long-term than INM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 6 TA indicator(s) are bullish.

  • INM’s TA Score: 6 bullish, 3 bearish.

Price Growth

INM (@Biotechnology) experienced а -2.59% price change this week, while SQZB (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

SQZB is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INM($3.86M) has a higher market cap than SQZB($885K). SQZB YTD gains are higher at: -6.667 vs. INM (-42.702).
INMSQZBINM / SQZB
Capitalization3.86M885K436%
EBITDA-7.44MN/A-
Gain YTD-42.702-6.667641%
P/E Ratio0.01N/A-
Revenue4.83MN/A-
Total Cash3.42MN/A-
Total Debt949KN/A-
FUNDAMENTALS RATINGS
INM: Fundamental Ratings
INM
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INM
RSI
ODDS (%)
Bullish Trend 12 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with OMER. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then OMER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-5.40%
OMER - INM
46%
Loosely correlated
-0.95%
TTNP - INM
44%
Loosely correlated
-0.65%
SPHDF - INM
33%
Poorly correlated
-7.23%
XFOR - INM
32%
Poorly correlated
-4.13%
SQZB - INM
29%
Poorly correlated
N/A
More

SQZB and

Correlation & Price change

A.I.dvisor tells us that SQZB and ATHA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SQZB and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
ATHA - SQZB
26%
Poorly correlated
+0.31%
OLMA - SQZB
13%
Poorly correlated
-3.69%
BRTX - SQZB
9%
Poorly correlated
-1.84%
BVAXF - SQZB
8%
Poorly correlated
+9.15%
ENTBF - SQZB
5%
Poorly correlated
N/A
More